Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference (2026-01-14)
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.